Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

31.19
+0.18000.58%
Post-market: 31.190.00000.00%19:50 EDT
Volume:591.39K
Turnover:18.44M
Market Cap:2.18B
PE:-10.42
High:31.55
Open:31.21
Low:30.69
Close:31.01
52wk High:43.25
52wk Low:20.65
Shares:69.86M
Float Shares:44.23M
Volume Ratio:0.89
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9943
EPS(LYR):-3.4871
ROE:-70.46%
ROA:-42.32%
PB:6.43
PE(LYR):-8.94

Loading ...

Pharvaris Currently Down 10 Consecutive Days, on Pace for Record Losing Streak

Dow Jones
·
Oct 02

Morgan Stanley Sticks to Its Buy Rating for Pharvaris (PHVS)

TIPRANKS
·
Sep 28

Pharvaris Insider Move Sparks Fresh Buzz on Wall Street

TIPRANKS
·
Sep 26

Insider Move at Pharvaris Sparks Fresh Investor Attention

TIPRANKS
·
Sep 25

Pharvaris Director Johannes Gerardus Christiaan Petrus Schikan Disposes of Common Shares Worth $28,952 in Cashless Option Exercise

Reuters
·
Sep 24

Top Pharvaris Executive Makes Attention-Grabbing Move With Company Stock

TIPRANKS
·
Sep 24

Pharvaris Chief Early Development Anne Lesage Disposes of USD 765,466 in Common Shares

Reuters
·
Sep 22

Pharvaris (PHVS) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Sep 22

Top Pharvaris Executive Cashes In on Major Insider Stock Sale

TIPRANKS
·
Sep 18

Pharvaris Chief Commercial Officer Wim Souverijns Sells USD 1.02 Million in Common Shares

Reuters
·
Sep 17

Morgan Stanley Reaffirms Their Buy Rating on Pharvaris (PHVS)

TIPRANKS
·
Sep 14

Pharvaris Director Robert Glassman Disposes of Common Shares Worth $300,396

Reuters
·
Sep 12

BioCryst Pharmaceuticals Faces Competitive Pressure in Hereditary Angioedema Treatment, RBC Says

MT Newswires Live
·
Sep 10

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

TIPRANKS
·
Sep 10

Pharvaris Price Target Raised to $65.00/Share from $50.00 by Leerink Partners

Dow Jones
·
Sep 10

Sweden's Biovica Q1 Sales Rise on Pharma Services Growth

Reuters
·
Sep 09

Pharvaris President Lu Peng Disposes of USD 610,134 Common Shares

Reuters
·
Sep 09

Pharvaris (PHVS) Gets a Buy from Leerink Partners

TIPRANKS
·
Sep 09

Pharvaris price target raised to $65 from $52 at Jones

TIPRANKS
·
Sep 09

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Sep 09